Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 9, 2001 - Issue 4
Submit an article Journal homepage
35
Views
55
CrossRef citations to date
0
Altmetric
Research Article

Short-term chlorambucil for refractory uveitis in Behcet's disease

A. Baki Mudun Department of Ophthalmology, SSK Okmeydani Training Hospital, and 2World Eye Hospital, Istanbul, Turkey
,
Andac Ergen Department of Ophthalmology, SSK Okmeydani Training Hospital, and 2World Eye Hospital, Istanbul, Turkey
,
Sermin Unal Ipcioglu Department of Ophthalmology, SSK Okmeydani Training Hospital, and 2World Eye Hospital, Istanbul, Turkey
,
Engin Yarkin Burumcek Department of Ophthalmology, SSK Okmeydani Training Hospital, and 2World Eye Hospital, Istanbul, Turkey
,
Yusuf Durlu Department of Ophthalmology, SSK Okmeydani Training Hospital, and 2World Eye Hospital, Istanbul, Turkey
&
M. Okan Arslan Department of Ophthalmology, SSK Okmeydani Training Hospital, and 2World Eye Hospital, Istanbul, TurkeyCorrespondence [email protected] [email protected]
Pages 219-229 | Published online: 08 Jul 2009

References

  • Behcet H. Ueber rezideivierende, aphthöse, durch em Virus verursachte Geschwilre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;46: 414–419'
  • Atmaca LS. Fundus changes associated with Behcet's disease. Arch Guth Exp Ophthalmol. 1989; 227:340–344.
  • Göztim N, Tugal Tutkun 1, Kasimoglu M, et al. Etiologic characteristics of uveitis in a 15 year follow-up. Med Bull Istanbul. 1992; 29:38–42.
  • BenEzra D, Cohen E. Treatment and visual prognosis in Behcet's disease. Br J Ophthalmol. 1986;70: 589–592.
  • Mamo JG, Baghdassarian A. Behcet's disease: a report of 28 cases. Arch Ophthalmol. 1964;71:4–14.
  • Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986;104:847–851.
  • Wong VG. Immunosuppressive therapy of ocular inflammatory diseases. Arch Ophthalmol. 1969;81: 628–637.
  • Yazici H, Pazarh H, Barnes CG. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med. 1990;322:281–285.
  • Kazokoglu H, Saatci 0, Cuhadaroglu H, et al. Long term effects of cyclophosphamide and colchicine treatment in Behcet's disease. Ann Ophthalmol. 1991;23: 148–151.
  • Ozyazgan Y, Yurdakul S, Yazici H, et al. Low dose cyclosporine-A versus pulsed cyclophosphamide in Behcet's disease. Br J Ophthalmol. 1992;76:241–243.
  • Mamo JG, Azzam SA. Treatment of Behcet's disease with chlorambucil. Arch Ophthalmol. 1970;84:446–450.
  • Bietti GB, Cerulli L, Pivetti Pezzi P. Behcet's disease and immunosuppressive treatment. Our personal experience. Mod Probl Ophthalmol. 1976;16:314–323.
  • Nozik RA, Godfrey WA, Ebstein WV, et al. Immunosuppressive treatment of uveitis. Mod Probl Ophthalmol. 1976;16:305–308.
  • Abdalla MI, El-Din Bagdat N. Long-lasting remission of Behcet's disease after chlorambucil therapy. Br J Ophthalmol. 1973;57:706–711.
  • Godfrey WA, Ebstein WV, O'Connor GR, et al. The use of chlorambucil in intractable idiopathic uveitis. Am J Ophthalmol. 1974;78:415–428.
  • Smoulders FM, Oosterhuis JA. Treatment of Behcet's disease with chlorambucil. Ophthalmologica. 1975;171:347–352.
  • Mamo JG. Treatment of Behcet's disease with chlorambucil. A follow-up report. Arch Ophthalmol. 1076; 94:580–583.
  • Tricoulis D. Treatment of Behcet's disease with chlorambucil. Br J Ophthalmol. 1976;60:55–57.
  • Palmer RG, Dore CJ, Denman AM. Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet. 1984;1(8370:246–249.
  • Tessler HH, Jennings T. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behcet's disease. Br J Ophthalmol. 1000;74:353–357.
  • International Study Group for Behcet's Disease. Evaluation of diagnostic ('classification') criteria in Behcet's disease: toward internationally agreed criteria. Lancet. 1000;335:1078–1080.
  • Tabbara KF. Chlorambucil in Behcet's disease. A reappraisal. Ophthalmology. 1983;90:906–908.
  • Nussenblatt RB, Palestine AG, Chan CC. Cyclosporine-A therapy in treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983;96:275–282.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.